Cardiovascular Systems, Inc. (CSII) News
Filter CSII News Items
CSII News Results
|Loading, please wait...|
CSII News Highlights
- CSII's 30 day story count now stands at 14.
- Over the past 27 days, the trend for CSII's stories per day has been choppy and unclear. It has oscillated between 1 and 7.
- The most mentioned tickers in articles about CSII are ST, CF and FORD.
Latest CSII News From Around the Web
Below are the latest news stories about Cardiovascular Systems Inc that investors may wish to consider to help them evaluate CSII as an investment opportunity.
Cardiovascular Systems (NASDAQ:CSII) has collaborated with Innova Vascular to develop a full line of novel thrombectomy devices. Thrombectomy is an interventional procedure performed to remove blood clots from arteries and veins. The company intends to acquire and commercialize novel thrombectomy devices from Innova targeting peripheral vascular disease, including deep vein thrombosis...
Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices
ST. PAUL, Minn., February 23, 2022--Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices
Cardiovascular Systems (CSII) exhibits a robust performance by its worldwide coronary franchise despite challenging business climate.
Cardiovascular Systems GAAP EPS of -$0.23 misses by $0.09, revenue of $59.1M misses by $3.56M, cuts FY guidance
Cardiovascular Systems press release (NASDAQ:CSII): Q2 GAAP EPS of -$0.23 misses by $0.09. Revenue of $59.1M (-7.9% Y/Y) misses by $3.56M. For the fiscal year ending June 30, 2022, CSI anticipates: Revenue of $235 million to $245 million from prior guidance of $265 million to $285 million vs. $270.17M consensus. Gross profit...
No summary available.
No summary available.
Cardiovascular Systems GAAP EPS of -$0.23 misses by $0.09, revenue of $59.1M misses by $3.56M, cuts FY fuidance
Cardiovascular Systems press release (CSII): Q2 GAAP EPS of -$0.23 misses by $0.09.Revenue of $59.1M (-7.9% Y/Y) misses by $3.56M.For the fiscal year ending June 30, 2022,
CSII earnings call for the period ending December 31, 2021.
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -64.29% and 5.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
ST. PAUL, Minn., February 03, 2022--CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2022 SECOND QUARTER FINANCIAL RESULTS